This week from Drug Target Review...
Dr Nicolas Camper at CDMO Abzena and colleagues offer insight into the landscape of antibody-drug conjugates and how the therapy is evolving.
TRENDING THIS WEEK
Autologous haematopoietic stem cell transplantation (aHSCT), a medical procedure typically employed in the treatment of blood cancers, holds promise as a potential therapy for individuals with relapsing-remitting multiple sclerosis (RRMS).?Read more>>>
Researchers from the University of Helsinki and the National Institutes of Health (NIH) in the United States have made a new discovery: the ectoderm, one of the germ layers, does not lose its pluripotency during gastrulation, contrary to prior beliefs. Read more>>>
Researchers have found that targeting chimeras with click-release proteolysis activates specific molecules that target cancer cells without harming health cells.?Read more>>>
WEHI researchers have found that a genetic change of MLKL increases risk of uncontrolled inflammatory response. Read more>>>
WHAT TO LISTEN TO
Tune into?our latest podcasts?which are curated with researchers and scientific leaders in mind. We sit down with industry experts and dive into the latest trends, research and innovation in drug discovery and early-phase therapeutic development.
领英推荐
Listen to our episodes?as we discuss topics such as multiplexed imaging, complex assays and organoids.
All caught up? Follow us on?Spotify,?Apple?and?Google Podcasts?to get notified when our next episode is live!
===
WHAT TO WATCH
Discover the latest trends and innovations in drug discovery with our range of?expert-led webinars.
Our?FREE one-hour sessions?cover a wide variety of topics, from the basics of drug discovery to the latest cutting-edge technologies and techniques. Whether you're a seasoned researcher or just starting out, our webinars offer valuable insights and practical advice to help you stay ahead of the curve.
Don't miss out on the opportunity to enhance your knowledge and skills.
===
SIGN UP FOR FREE
Stay connected with the most pressing topics and trends in global drug discovery and early-phase therapeutic development.
Drug Target Review?is an essential multimedia resource for researchers and scientific leaders covering the latest innovation and cutting-edge technological progression in the industry.?Sign up for FREE access to breaking news, thought leadership and expert insights.?
Want to keep up to date with our latest content? Follow us on?LinkedIn,?Facebook,?Twitter?and?YouTube.
Get involved in the conversation?#DTRTalks